Malignant Gliomas in Adults
Patrick Y Wen;Santosh Kesari.
The New England Journal of Medicine (2008)
Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
Patrick Y. Wen;David R. Macdonald;David A. Reardon;Timothy F. Cloughesy.
Journal of Clinical Oncology (2010)
Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
Henry S. Friedman;Michael D. Prados;Patrick Y. Wen;Tom Mikkelsen.
Journal of Clinical Oncology (2009)
AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma Patients
Tracy T. Batchelor;A. Gregory Sorensen;A. Gregory Sorensen;Emmanuelle di Tomaso;Wei Ting Zhang;Wei Ting Zhang.
Cancer Cell (2007)
Exciting New Advances in Neuro-Oncology The Avenue to a Cure for Malignant Glioma
Erwin Van Meir;Constantinos G Hadjipanayis;Andrew D. Norden;Hui-Kuo Shu.
CA: A Cancer Journal for Clinicians (2010)
Epidemiology of Brain Metastases
Lakshmi Nayak;Eudocia Quant Lee;Patrick Y. Wen.
Current Oncology Reports (2012)
Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence.
A. D. Norden;G. S. Young;K. Setayesh;A. Muzikansky.
Practice parameter: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors Report of the Quality Standards Subcommittee of the American Academy of Neurology
M. J. Glantz;B. F. Cole;B. F. Cole;P. A. Forsyth;L. D. Recht;L. D. Recht.
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
Derin B. Keskin;Annabelle J. Anandappa;Jing Sun;Itay Tirosh.
Stereotactic Radiosurgery for the Definitive, Noninvasive Treatment of Brain Metastases
Eben Alexander;Thomas M. Moriarty;Roger B. Davis;Patrick Y. Wen.
Journal of the National Cancer Institute (1995)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: